FR2592048A1 - Inhibiteurs d'ureido-renine, a action therapeutique - Google Patents

Inhibiteurs d'ureido-renine, a action therapeutique

Info

Publication number
FR2592048A1
FR2592048A1 FR8616673A FR8616673A FR2592048A1 FR 2592048 A1 FR2592048 A1 FR 2592048A1 FR 8616673 A FR8616673 A FR 8616673A FR 8616673 A FR8616673 A FR 8616673A FR 2592048 A1 FR2592048 A1 FR 2592048A1
Authority
FR
France
Prior art keywords
bopi
ureido
therapeutic action
renin inhibitors
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8616673A
Other languages
English (en)
Other versions
FR2592048B1 (fr
Inventor
Sesha Iyer Natarajan
Denis Evan Ryono
Edward William Petrillo Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of FR2592048A1 publication Critical patent/FR2592048A1/fr
Application granted granted Critical
Publication of FR2592048B1 publication Critical patent/FR2592048B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0227—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
    • C07C275/14—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Composés de formule (CF DESSIN DANS BOPI) dans laquelle, de préférence : X est (CF DESSIN DANS BOPI) R1 est (CF DESSIN DANS BOPI) ou -CH-(CH3)2 ; R2 est un atome d'hydrogène ou un groupement -CH2-CH-(CH3)2, ou -CH-(CH3)2 ; R5 est (CF DESSIN DANS BOPI) R4 est (CF DESSIN DANS BOPI) R3 est -CH2-CH-(CH3)2 ; R9 est (CF DESSIN DANS BOPI) ou (CF DESSIN DANS BOPI) R10 est -0-CH3 ; q est égal à un. Ces composés interviennent dans la transformation de l'angiotensinogène en angiotensine II en inhibant la rénine, et ils sont donc utiles comme agents antihypertenseurs.
FR8616673A 1985-12-23 1986-11-28 Inhibiteurs d'ureido-renine, a action therapeutique Expired - Fee Related FR2592048B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81256185A 1985-12-23 1985-12-23

Publications (2)

Publication Number Publication Date
FR2592048A1 true FR2592048A1 (fr) 1987-06-26
FR2592048B1 FR2592048B1 (fr) 1995-07-07

Family

ID=25209973

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8616673A Expired - Fee Related FR2592048B1 (fr) 1985-12-23 1986-11-28 Inhibiteurs d'ureido-renine, a action therapeutique

Country Status (6)

Country Link
JP (1) JPS62164658A (fr)
CA (1) CA1297631C (fr)
DE (1) DE3643977A1 (fr)
FR (1) FR2592048B1 (fr)
GB (1) GB2184730B (fr)
IT (1) IT1213574B (fr)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599198A (en) * 1985-08-02 1986-07-08 Pfizer Inc. Intermediates in polypeptide synthesis
US5049548A (en) * 1989-03-03 1991-09-17 Merck & Co., Inc. Renin-inhibitory di-, tri-, and tetrapeptides
US5614522A (en) * 1990-11-19 1997-03-25 G.D. Searle & Co. Retroviral protease inhibitors
CA2096408C (fr) * 1990-11-19 2005-02-08 Gary Anthony Decrescenzo Inhibiteurs de la protease des retrovirus
US5482947A (en) * 1990-11-19 1996-01-09 Talley; John J. Retroviral protease inhibitors
US5475013A (en) * 1990-11-19 1995-12-12 Monsanto Company Retroviral protease inhibitors
US5648511A (en) * 1990-11-19 1997-07-15 G.D. Searle & Co. Method for making intermediates useful in the synthesis of retroviral protease inhibitors
EP0558603B1 (fr) * 1990-11-19 1998-08-26 Monsanto Company Inhibiteurs de proteases retrovirales
US5708004A (en) * 1990-11-19 1998-01-13 Monsanto Company Retroviral protease inhibitors
US5475027A (en) * 1990-11-19 1995-12-12 G.D. Searle & Co. Retroviral protease inhibitors
DE69132423T2 (de) 1990-11-19 2001-04-26 Monsanto Co Inhibitoren retroviraler Proteasen
US5583238A (en) * 1990-11-19 1996-12-10 G. D. Searle & Co. Method for making intermediates useful in synthesis of retroviral protease inhibitors
ATE141265T1 (de) * 1992-05-20 1996-08-15 Searle & Co Verfahren zur herstellung von intermediaten in der synthese von retroviralen protease inhibitoren
EP0641325B1 (fr) * 1992-05-21 2001-03-07 Monsanto Company Inhibiteurs de protease retrovirale
US6743929B1 (en) 1992-08-25 2004-06-01 G. D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
US5760076A (en) * 1992-08-25 1998-06-02 G.D Searle & Co. Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
DE69311810T2 (de) * 1992-08-25 1997-11-27 Searle & Co N-(alkanoylamino-2-hydroxypropyl)-sulfonamide verwendbar als retrovirale proteaseninhibitoren
US6022994A (en) * 1992-08-25 2000-02-08 G. D. Searle &. Co. Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
CA2140928C (fr) * 1992-08-25 2008-01-29 Michael L. Vazquez Sulfonylalcanoylaminohydroxyethylaminosulfonamides utiles comme inhibiteurs de la protease retrovirale
US7141609B2 (en) 1992-08-25 2006-11-28 G.D. Searle & Co. α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
US6046190A (en) * 1992-08-25 2000-04-04 G.D. Searle & Co. Hydroxyethylamino sulphonamides useful as retroviral protease inhibitors
US5968942A (en) 1992-08-25 1999-10-19 G. D. Searle & Co. α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
US5843946A (en) 1992-08-25 1998-12-01 G.D. Searle & Co. α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
US5830897A (en) * 1992-08-27 1998-11-03 G. D. Searle & Co. α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
US6337398B1 (en) 1992-10-30 2002-01-08 G.D. Searle & Co. Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors
ES2196436T3 (es) * 1992-10-30 2003-12-16 Searle & Co Acidos sulfonilalcanoilamino-hidroxietilamino-sulfamicos utiles como inhibidores de proteasas retrovirales.
US5578606A (en) * 1992-10-30 1996-11-26 G. D. Searle & Co. α- and β-amino acid hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors
US5756498A (en) * 1992-10-30 1998-05-26 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors
ATE211462T1 (de) 1992-10-30 2002-01-15 Searle & Co N-substituierte hydroxyethylaminosulfamidsäure- derivate verwendbar als inhibitoren retroviraler proteasen
US5514801A (en) * 1992-12-29 1996-05-07 Monsanto Company Cyclic sulfone containing retroviral protease inhibitors
US5830888A (en) * 1993-04-16 1998-11-03 Monsanto Company Macrocyclic retroviral protease inhibitors
US5750648A (en) * 1993-08-20 1998-05-12 G.D. Searle & Co. Retroviral protease inhibitors and combinations thereof
US5602119A (en) * 1993-10-29 1997-02-11 Vazquez; Michael L. Succinoylamino hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors
US6133444A (en) * 1993-12-22 2000-10-17 Perseptive Biosystems, Inc. Synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions
DE69515465T2 (de) * 1994-11-04 2000-08-03 Santen Pharmaceutical Co Ltd Neue hydroxy-substituierte 1,3-dialkyl-harnstoffderivate
US5831117A (en) 1995-01-20 1998-11-03 G. D. Searle & Co. Method of preparing retroviral protease inhibitor intermediates
EP1586558A3 (fr) 1995-01-20 2005-10-26 G.D. Searle LLC. Inhibiteurs hydroxyethylamino contenant des bis-sulfinamides utilises pour inhiber des proteases retrovirales
US6140505A (en) 1995-03-10 2000-10-31 G. D. Searle & Co. Synthesis of benzo fused heterocyclic sulfonyl chlorides
US5756533A (en) * 1995-03-10 1998-05-26 G.D. Searle & Co. Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US5776971A (en) * 1995-03-10 1998-07-07 G.D. Searle & Co. Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US6667307B2 (en) 1997-12-19 2003-12-23 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US6407134B1 (en) 1995-03-10 2002-06-18 G. D. Searle & Co. Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US6861539B1 (en) 1995-03-10 2005-03-01 G. D. Searle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
EP1188766A1 (fr) 1995-03-10 2002-03-20 G.D. Searle & Co. Hydroxyethylamino sulfonamide de bis-aminoacide comme inhibiteurs de proteases de retrovirus
US7339078B2 (en) 1995-03-10 2008-03-04 G.D. Searle Llc Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US5985870A (en) * 1995-03-10 1999-11-16 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US6150556A (en) 1995-03-10 2000-11-21 G. D. Dearle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US6169085B1 (en) 1995-03-10 2001-01-02 G. D. Searle & Company Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US5705500A (en) * 1995-03-10 1998-01-06 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
RU2174519C2 (ru) 1995-03-10 2001-10-10 Джи. Ди. Сирл Энд Ко. Гидроксиэтиламино сульфонамиды гетероциклокарбонил аминокислоты, ингибирующие ретровирусную протеазу
WO1997018205A1 (fr) * 1995-11-15 1997-05-22 G.D. Searle & Co. Inhibiteurs de proteases retrovirales a base de sulfonylalcanoylamino hydroxyethylamino sulfonamides substitues
BR9815469A (pt) * 1997-05-08 2001-03-06 Smithkline Beecham Corp Inibidores de protease
WO2000002862A1 (fr) 1998-07-08 2000-01-20 G.D. Searle & Co. Inhibiteurs de la protease retrovirale
WO2002014264A2 (fr) * 2000-08-11 2002-02-21 The Brigham And Women's Hospital, Inc. (hydroxyethyl)urees utilisees en tant qu'inhibiteurs de la production de beta-amyloide de la maladie d'alhzeimer
KR100750102B1 (ko) 2001-06-14 2007-08-17 삼성전자주식회사 디스크 카트리지
GEP20074221B (en) 2001-07-11 2007-10-25 Elan Pharm Inc N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
US7351738B2 (en) * 2002-11-27 2008-04-01 Elan Pharmaceuticals, Inc. Substituted ureas and carbamates

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0104041A1 (fr) * 1982-09-15 1984-03-28 Aktiebolaget Hässle Inhibiteurs d'enzyme
WO1984003044A1 (fr) * 1983-02-07 1984-08-16 Ferring Ab Inhibiteurs enzymatiques
EP0159156A1 (fr) * 1984-03-30 1985-10-23 E.R. Squibb & Sons, Inc. Uréidoamino- et -imino-acides hydroxy substitués

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599198A (en) * 1985-08-02 1986-07-08 Pfizer Inc. Intermediates in polypeptide synthesis

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0104041A1 (fr) * 1982-09-15 1984-03-28 Aktiebolaget Hässle Inhibiteurs d'enzyme
WO1984003044A1 (fr) * 1983-02-07 1984-08-16 Ferring Ab Inhibiteurs enzymatiques
EP0159156A1 (fr) * 1984-03-30 1985-10-23 E.R. Squibb & Sons, Inc. Uréidoamino- et -imino-acides hydroxy substitués

Also Published As

Publication number Publication date
GB8630006D0 (en) 1987-01-28
GB2184730A (en) 1987-07-01
IT8622804A0 (it) 1986-12-22
CA1297631C (fr) 1992-03-17
FR2592048B1 (fr) 1995-07-07
GB2184730B (en) 1990-02-07
DE3643977A1 (de) 1987-07-02
JPS62164658A (ja) 1987-07-21
IT1213574B (it) 1989-12-20

Similar Documents

Publication Publication Date Title
FR2592048A1 (fr) Inhibiteurs d'ureido-renine, a action therapeutique
EP0202577A3 (fr) N-(acyldipeptidyl)-aminoglycols
KR880009910A (ko) 리폭시게네이즈 억제 화합물
FR2456733A1 (fr) Nouveaux acides 2-(mercapto-1-oxo(alkyl inferieur))-1,2,3,4-tetrahydroisoquinoleine-3-carboxyliques, utiles notamment comme inhibiteurs de l'enzyme de conversion de l'angiotensine i
NO924929L (no) Farmasoeytisk aktive benzoquinazolinforbindelser
NO860852L (no) Tilling derav.
PT1044186E (pt) Composto 2-benzilamino-2-fenil-acetamida substituidos
ATE51618T1 (de) Imidazolderivate, verfahren zu deren herstellung, deren anwendung und pharmazeutische zusammenstellungen.
DE69808099T2 (de) Substituierte 6-alkylphenanthridine
ES539123A0 (es) Un compuesto de 3-indolcarboxamida
NO163957C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive karbapenemforbindelser.
ATE50773T1 (de) Alkylresorcinolphosphite.
ES2038710T3 (es) Un procedimiento de preparacion de un derivado de benzoxazina y su utilizacion.
FR2631827B1 (fr) Nouveaux derives d'(hetero)aryl-5 tetrazole, leur procede de preparation et leur application en therapeutique
ATE71092T1 (de) Hydroxybutenolid-derivate, ihre herstellung und ihre verwendung.
FR2447383A1 (fr) Acides mercaptoacylpyrrolidine- et mercaptoacylpiperidine-phosphoniques, a action antihypertensive
ES2041679T3 (es) Compuestos analgesicos de octohidroindolizinas 5-substituidas y productos intermedios 7-ceto.
ATE55907T1 (de) Oktahydroindolizine brauchbar als analgetika.
FI861947A (fi) Hexensyror.
TNSN91055A1 (fr) Nouvelles tetrahydroimidazo (1,4) benzodiazepine -2-(thi) ones
ATE151987T1 (de) Verwendung von 3-pyridazinone zur verringerung der blutplätchenzahl
FR2450835A2 (fr) Derives de la tetrahydroalstonine et leur application en therapeutique
FR2453138A1 (fr) Tetradecapeptides lineaires, intermediaires de synthese d'homologues de somatostatine
FR2450824A1 (fr) Nouveaux derives d'acides 1-(o-mercaptoacyl)-5-pyrazolidinone-3-carboxyliques, utiles notamment comme agents hypotenseurs
MX9702941A (es) Compuestos de di-ter - butilfenol que tiene una porcion heterociclica, utiles como agentes anti-inflamatorios.

Legal Events

Date Code Title Description
ST Notification of lapse